Prosecution Insights
Last updated: November 17, 2026
Application No. 17/757,359

PULMONARY VEIN ISOLATION CATHETERS AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS

Final Rejection §103
Filed
Jun 14, 2022
Priority
Dec 16, 2019 — provisional 62/948,736 +2 more
Examiner
LEE, DAVINA EN-YIN
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Affera Inc.
OA Round
4 (Final)
39%
Grant Probability
At Risk
5-6
OA Rounds
57%
With Interview

Examiner Intelligence

Grants only 39% of cases
39%
Career Allowance Rate
23 granted / 59 resolved
-31.0% vs TC avg
Strong +18% interview lift
Without
With
+17.6%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
31 currently pending
Career history
111
Total Applications
across all art units

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment filed 01 May 2026 has been entered. Claims 1, 6, 15, 22-23, and 76 are currently amended. Claims 77-78 are new. Claims 1, 3-7, 9-11, 15-23, 25-33, 35, and 76-78 are pending in the application. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 4, 5, 15, 25-33, and 35 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev et al. (US PGPub No. 2017/0312420), hereinafter Harlev. Regarding claim 1, Harlev teaches a catheter comprising: a shaft having a proximal end portion and a distal end portion (Fig. 2: catheter shaft 122); and a tip section mechanically coupled to the distal end portion of the shaft (Figs. 2, 21: ablation electrode 124, 224; par. 0196: “The coupling portion 140 of the ablation electrode 124 can be directly or indirectly mechanically coupled to the catheter shaft 122”), wherein the tip section includes a plurality of struts defining a plurality of cells (Fig. 21: struts 244b; par. 0307: “an ablation electrode 224 having struts 244b defining a plurality of cells 247”) that together define an expandable portion (par. 0187: “the ablation electrode 124 expands from a compressed state during delivery to an expanded state during treatment at the treatment site”), and at least some cells of the plurality of cells define an electrode to deliver electrical energy to tissue of a patient (par. 0197: “electrical energy provided at the generator 116 can be delivered to the coupling portion 140 and, thus, to the deformable portion 142 of the ablation electrode 124, where the electrical energy can be delivered to tissue of the patient 102;” par. 0213: “In the uncompressed state, the struts 144b, the joints 141a, and the cells 147 together can form an open framework having a conductive surface along the deformable portion 142 of the ablation electrode 124”), wherein at least one mesh electrode panel of the plurality of mesh electrode panels includes at least one keyed portion at an end of the respective mesh electrode panel (Figs. 10, 12B: struts 144a), and wherein: the at least one keyed portion is configured to interface with a mating portion of a first coupler at the distal end portion of the shaft to mechanically couple the respective at least one mesh electrode panel to the first coupler (par. 0196: “the coupling portion 140 can include struts 144a directly coupled to the catheter shaft 122 or coupled to a transition part coupled to the catheter shaft 122 […] the coupling portion 140 can include a complete ring directly or indirectly mechanically coupled to the catheter shaft 122;” examiner notes that as the limitations of this claim regarding keyed portions are stated in the alternative, the claim is considered to be met by the prior art when only one of the limitations are met). Harlev teaches wherein the struts are fastened together in a mesh electrode structure (par. 0307: “an ablation electrode 224 having struts 244b defining a plurality of cells 247, with the struts 244b progressively ganged together in a direction from a proximal region to a distal region of a deformable portion 242 of the ablation electrode 224”), but does not explicitly teach wherein the mesh electrode structure includes a plurality of mesh electrode panels. However, it would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to construct the mesh electrode structure from a plurality of mesh electrode panels, since it has been held that constructing a formerly integral structure in various elements involves only routine skill in the art. Nerwin v. Erlichman, 168 USPQ 177, 179. Regarding claim 4, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein a first subset of the plurality of struts are coupled together to define a plurality of cells for each mesh electrode panel (Fig. 22 and par. 0307: “an ablation electrode 224 having struts 244b defining a plurality of cells 247, with the struts 244b progressively ganged together”). Regarding claim 5, Harlev teaches the catheter of claim 4 as described previously. Harlev further teaches wherein the plurality of cells define, at least in part, an open area of the expandable portion through which fluid, blood, or a combination thereof can flow (par. 0194: “the ablation electrode 124 can have greater than about 50 percent open area and less than about 95 percent open area (e.g., about 80 percent open area) […] the open area of the ablation electrode 124 can facilitate the flow of irrigation fluid and blood through ablation electrode 124 during treatment”). Regarding claim 15, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein each of the mesh electrode panels of the plurality of mesh electrode panels includes at least one eyelet (Fig. 12B: eyelets 157), and wherein at least one fastener holds adjacent mesh electrode panels together via corresponding eyelets (Figs. 12C, 21: fastener 141b, 241b; par. 0246: “the fastener 141b can couple the portion of the struts 144b to one another at the eyelets 157”). Regarding claim 25, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein at least one of the mesh electrode panels includes: a first strut mechanically coupled to the distal end portion of the shaft; a second strut coupled to the first strut at a proximal-most portion of the second strut; and a third strut coupled to the first strut at a proximal-most portion of the third strut (Fig. 21: struts 244b coupled to one another as well as to the distal end portion of the shaft 222). Regarding claims 26-27, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein at least one mesh electrode panel includes a proximal portion, a distal portion, and a middle portion or equator between the proximal portion and the distal portion, and wherein the middle portion is wider than the proximal and the distal portion, or the expandable portion includes a greater number of cells of the plurality of cells about the equator than about the distal section and/or about the proximal section (see annotated Fig. 21 with outlined mesh electrode panel wider and having more cells around the middle portion/equator; see also par. 0308: “the struts 244b can be progressively ganged together in the direction toward the distal end of the deformable portion 242 such that the number of cells 247 defined by the struts decreases in the direction toward the distal end of the deformable portion 242. Thus, as compared to a configuration in which struts are uniformly disposed about a shape, the closed end of the deformable portion 242 of the ablation electrode 224 can be formed by joining together relatively few of the struts 244b. This can be advantageous with respect to, for example, achieving acceptable manufacturing tolerances or, further or instead, facilitating substantially uniform distribution of current density along the deformable portion 242”). PNG media_image1.png 626 790 media_image1.png Greyscale Annotated Figure 21 Regarding claims 28-30, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein a first subset of the plurality of struts defines a plurality of cells of the expandable portion (par. 0202: “each cell 147 can be defined by at least three struts 144b”); and at least one cell of the plurality of cells, namely a distalmost or proximal-most cell, is formed by (i) a first strut of the first subset belonging to a first one of the mesh electrode panels and (ii) a second strut of the first subset belonging to a second one of the mesh electrode panels different from the first one (par. 0202: “each strut 144b can define a portion of at least two of the cells 147”). Regarding claim 31, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein the electrode panels each comprise a plurality of struts; the plurality of struts includes (i) a first subset of struts having one or more first lengths (Fig. 21: longer struts towards distal end of ablation electrode 224) and (ii) a second subset of struts having one or more second lengths smaller than the one or more first lengths; and the first subset of struts includes a distalmost strut of the plurality of struts or a proximal-most strut of the plurality of struts (Fig. 21: distalmost struts shorter than the long struts of the first subset; examiner notes that as the conditions in the limitations of this claim are stated in the alternative, the claim is considered to be met when the prior art reads on only one of each condition). Regarding claim 32, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein the plurality of struts defines a plurality of cells of the expandable portion; and at least one cell of the plurality of cells is formed by at least four struts (Fig. 21: each diamond-shaped cell 247 formed by at least four struts). Regarding claim 33, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein a strut may include a first portion having a first width and a second portion having a second width smaller than the first width (par. 0206: “at least some of the struts 144b can include a width increasing along the length of the respective strut 144b in a direction from a proximal region to a distal region of the ablation electrode 124”), which provides the ability to adjust current density distribution (par. 0206: “at least some of the struts 144b can have a non-uniform width along a length of the respective strut 144b such that the amount of material along a given strut is varied, resulting in an associated distribution in current density”). Harlev does not explicitly teach wherein the strut with non-uniform width is a proximal-most strut, but it would have been an obvious matter of design choice to one of ordinary skill in the art, before the effective filing date of the claimed invention, to provide non-uniform width at a proximal-most strut of Harlev’s ablation electrode in order to adjust current density distribution at the proximal area of the electrode, since applicant has not disclosed that non-uniform width in the proximal-most strut solves any stated problem or is for any particular purpose and it appears that the invention would perform equally as well with non-uniform width in any selected strut where an adjustment of current density would be necessary. Regarding claim 35, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein, in the absence of external force, the expandable portion assumes a deployed state having a diameter greater than a largest diameter of the shaft (Fig. 21: diameter of ablation electrode 224 greater than diameter of shaft 222; par. 0212: “the deformable portion 142 can be expandable (e.g., self-expandable) from the compressed state to the uncompressed state. For example, the struts 144b can be biased to move in one or more directions away from one another to self-expand the deformable portion 142 from the compressed state to the uncompressed state”). Claims 3 and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Falwell et al. (US Patent No. 8,527,027), hereinafter Falwell. Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein areas of the electrode can be electrically isolated from one another (par. 0193: “the ablation electrode 124 can include electrically isolated portions such that the ablation electrode 124 includes two electrodes of a bipolar electrode configuration”) but does not explicitly teach wherein the active conductive portion is distal to the insulated portion or wherein the mesh electrode panels of the expandable portion are electrically isolated from one another such that electrical energy can be delivered from any one of the mesh electrode panels independently from the other of the mesh electrode panels. However, in an analogous art, Falwell teaches an ablation catheter with mesh electrode panels wherein an active conductive portion is positioned relative to an insulated portion to face an intended direction of ablation (col 9, lines 11-17: “The insulation may also be removed in a preferential manner so that a particular portion of the circumferential surface of a filament 34 is exposed. In this manner, when braided conductive member 28 is radially expanded, the stripped portions to of filaments may preferentially face an intended direction of mapping or ablation”), wherein the insulated portion allows the areas of the electrode to be activated independently or concurrently (col 9, lines 21-22: “The mapping and ablation filaments may be activated independently or may be activated concurrently”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to position the active conductive portion relative to the insulated portion to face an intended direction of ablation (that is, a distal direction) and isolate the electrode portions from one another, as suggested by Falwell, so that the insulated portion may allow areas of the electrode to be activated independently or concurrently, as taught by Falwell. Claims 6-7 and 23 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Govari et al. (US PGPub No. 2019/0217065), hereinafter Govari ‘065. Regarding claims 6-7, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches wherein the tip section further includes a deployment member mechanically coupled to the expandable portion (par. 0272: “a catheter such as any one or more of the catheters described herein can include a sliding member extending from the handle, though a catheter shaft, and to an ablation electrode. The sliding member can be coupled (e.g., mechanically coupled) to the ablation electrode such that axial movement of the sliding member relative to the catheter shaft can exert compression and/or expansion force on the deformable portion of the ablation electrode”), but does not explicitly teach wherein the deployment member is mechanically coupled at the distalmost portion of the tip section, or wherein the expandable portion envelops at least a portion of the deployment member between the distal end portion of the shaft and the distalmost portion of the tip section, or wherein the deployment member is telescoping. However, in an analogous art, Govari ‘065 teaches a catheter comprising a telescoping deployment member for an expandable component coupled to a distalmost portion of an expandable end effector (Figs. 2A-3B: telescopic assembly 40, puller wire 52; par. 0034: “When physician 30 is ready to inflate balloon 44, the physician command compressing telescopic balloon assembly 40, which is performed by pulling of puller-wire 52. As seen in FIG. 2B, the two-part telescopic assembly 40 is compressed by pulling puller-wire 52 proximally forcefully enough for distal section 46 to force one or more elastic splines 50 to bend”). Govari ‘065 teaches that this configuration allows the deployment to be controlled by pulling motions only, rather than pulling and pushing, which results in a more flexible catheter (par. 0026: “When using the disclosed configurations, the puller-wire may be very thin and highly flexible. This feature is in contrast to solutions based on pusher-wire, in which the pusher-wire must be rigid and therefore thick and less flexible. As such, the disclosed techniques, enable highly flexible catheter designs capable of performing sharp turns. A highly flexible balloon catheter using the disclosed telescopic assembly assisted by a puller-wire may thus particularly maneuverable via sharp deflections of blood vessels, and by so overcoming an obstacle that may otherwise hinder catheterization”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of Harlev by configuring the deployment member to be telescoping and coupled to the distalmost portion of the expandable portion, as taught by Govari ‘065, in order to allow the catheter to be more flexible, as taught by Govari ‘065. Regarding claim 23, Harlev teaches the catheter of claim 1 as described previously. Harlev further teaches a first strut, a second strut coupled to the first strut at distalmost portion of the second strut; and a third strut coupled to the first strut at a distalmost portion of the third strut (Fig. 21: struts 244 coupled to one another) but does not explicitly teach wherein the first strut is mechanically coupled to a deployment member at the distalmost portion of the tip section. However, Harlev in view of Govari ‘065 teaches this limitation for the same reasons set forth in the rejection of claims 6-7. Claim 9 is rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Govari ‘065 and further in view of Kunis et al. (US PGPub No. 2013/0116688), hereinafter Kunis. Harlev in view of Govari ‘065 teaches the catheter of claim 6 as described previously. The combination does not explicitly teach wherein the deployment member defines a lumen configured to receive the guidewire. However, in an analogous art, McDaniel teaches a pulmonary vein ablation catheter with a deployment member (Fig. 3: control shaft 57), wherein the deployment member defines a lumen configured to receive a guidewire (Fig. 3: guidewire lumen 63), which allows the ablation catheter to be percutaneously inserted into the vasculature of a patient over a guidewire (par. 0083). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to provide the deployment member of the combined reference with a lumen for receiving the guidewire, as taught by Kunis, so that the ablation catheter to be percutaneously inserted into the vasculature of a patient over a guidewire, as taught by Kunis. Claims 10-11 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Govari ‘065 and further in view of Tegg et al. (US PGPub No. 2010/0168647), hereinafter Tegg. Harlev in view of Govari ‘065 teaches the catheter of claim 6 as described previously. The combination does not explicitly teach wherein the deployment member defines a lumen, and wherein the lumen is configured to transport fluid at least between the proximal end portion of the shaft and the distalmost portion of the tip section, or includes a plurality of holes configured to disperse fluid radially from within the expandable portion toward an inner surface of the expandable portion. However, in an analogous art, Tegg teaches a basket catheter with a deployment member wherein the deployment member defines a lumen configured to transport fluid to the distalmost portion of the tip section (Fig. 3b: deployment member 31, distal portion 42; par. 0042: “the deployment member 31 may be a tubing (or house a tubing) fluidically connected on one end to a fluid source, and on the other end to the distal fluid delivery ports 34a' provided on the deployment member 31”), including a plurality of holes configured to disperse fluid radially from within the expandable portion toward an inner surface of the expandable portion (Fig. 3b: plurality of fluid delivery ports 34a’ configured to disperse fluid radially from within the splines 36). Tegg further teaches that providing irrigation with a basket catheter reduces clotting or thrombus formation (par. 0013: “The basket catheter also includes a fluid delivery tube housed within the basket catheter. The fluid delivery tube has at least one fluid delivery port for irrigating within the basket catheter between the plurality of splines to reduce clotting or thrombus formation”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of the combined reference by configuring the deployment member to transport and disperse fluid radially from within the expandable portion, as taught by Tegg, in order to reduce clotting or thrombus formation, as taught by Tegg. Claims 16 and 18-19 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Govari et al. (US PGPub No. 2017/0172442), hereinafter Govari ‘442. Regarding claim 16, Harlev teaches the catheter of claim 15 as described previously, but does not explicitly teach wherein the at least one fastener includes at least one sensor, and wherein the at least one sensor includes at least one electrode or a temperature measurement device. However, in an analogous art, Govari ‘442 teaches a catheter with an expandable basket assembly comprising at least one sensor at a fastener, wherein the at least one sensor includes at least one electrode (Fig. 3 and par. 0048: “a distal electrode location sensor 65 mounted at or near the position where the distal ends of the spines are connected”) so that positions of electrodes on the expandable assembly can be determined (par. 0048: “the coordinates of the electrode location sensor 65 relative to those of the electrode location sensor 67 can be determined and taken together with known information pertaining to the curvature of the splines 45 to find the positions of each of the spline electrodes 49”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify the catheter of Harlev by including a sensor on the distal fastening structure, as taught by Govari ‘442, in order to determine positions of electrodes on the expandable assembly can be determined, as taught by Govari ‘442. Regarding claim 18, the combination teaches the catheter of claim 16 as described previously. Govari ‘442 further teaches wherein an electrical lead extends from the at least one sensor, within an interior of the expandable portion, and into the shaft (Figs. 2-3; par. 0041: “The outer diameter of the shaft 39 is not critical, but is preferably no more than about 8 french, more preferably 7 french. Likewise the thickness of the outer wall is not critical, but is preferably thin enough so that the central lumen can accommodate a puller wire, lead wires, sensor cables and any other wires, cables or tubes;” examiner notes that a sensor cable extending from shaft 39 to distal sensor 65 necessarily extends within an exterior of the expandable portion and into the shaft). The combination does not explicitly teach wherein an additional sensor is formed by or positioned on the electrical lead within the interior of the expandable portion. However, Harlev further teaches a center electrode within the interior of the expandable portion (Fig. 21: center electrode 235) that can be used together with sensors on the exterior of the expandable portion to provide near-unipolar electrograms (par. 0237: “the sensors 126 and a center electrode can cooperate to provide near-unipolar electrograms”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify the catheter of the combined reference by placing an additional sensor on the electrical lead within the interior of the expandable portion, that is, in the center of the expandable portion, as taught by Harlev, so that it can be used together with sensors on the exterior of the expandable portion to provide near-unipolar electrograms, as taught by Harlev. Regarding claim 19, Harlev teaches the catheter of claim 1 as described previously, but does not teach further comprising a displacement measuring device configured to measure a displacement of a deployment member mechanically coupled to the expandable portion to determine a shape of the expandable portion. However, Govari ‘442 teaches a displacement measuring device configured to measure a displacement of a deployment member mechanically coupled to an expandable portion (Figs. 2-3: basket-shaped electrode assembly 43, contraction wire 47, electrode location sensors 65 and 67; par. 0042: “When the contraction wire 47 is moved longitudinally to expand and contract the electrode assembly 43, in the expanded position the splines 45 are bowed outwardly and in the contracted position the splines 45 are generally straight”) to determine a shape of the expandable portion, positions of electrodes on the expandable assembly can be determined (par. 0048: “the catheter 37 is provided with a distal electrode location sensor 65 mounted at or near the position where the distal ends of the spines are connected, and a proximal electrode location sensor 67 mounted at or near the proximal end of the electrode assembly 43, whereby, in use, the coordinates of the electrode location sensor 65 relative to those of the electrode location sensor 67 can be determined and taken together with known information pertaining to the curvature of the splines 45 to find the positions of each of the spline electrodes 49”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of Harlev by providing distal and proximal electrode location sensors for determining the shape of the expandable portion, as taught by Govari ‘442, in order to determine positions of electrodes on the expandable assembly can be determined, as taught by Govari ‘442. Claim 17 is rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Govari ‘442 and further in view of Tran et al. (US PGPub No. 2017/0281268), hereinafter Tran. Harlev in view of Govari ‘442 teaches the catheter of claim 16 as described previously. Harlev further teaches wherein the at least one eyelet of each of the mesh electrode panels is directly connected to at least one strut (par. 0084: “the second end region of each respective strut of the portion of struts can define an eyelet”), but the combination does not explicitly teach wherein the at least one strut includes a bend such that the at least one sensor is recessed relative to an exterior of the expandable portion when the adjacent mesh electrode panels are held together via the at least one fastener. However, in an analogous art, Tran teaches providing a bend in struts of a basket catheter such that a fastening structural element is recessed relative to an exterior of the expandable basket (Fig. 5: bends in spines 18 such that cap 24 is recessed; par. 0046: “distal portions of spines 18 that exhibit a concave configuration”), which keeps the structural element flush with the outer curvature for a relatively blunt and atraumatic surface (par. 0046: “This invaginated design keeps the top of basket-shaped electrode assembly 16 approximately flush with the outer curvature for safety reasons, by presenting a relatively blunt and atraumatic surface”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of the combined reference by providing a bend in the struts of the mesh electrode panels such that the fastener and sensor are recessed relative to an exterior of the expandable portion, as suggested by Tran, in order to achieve a relatively blunt and atraumatic surface, as taught by Tran. Claim 20 is rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of de la Rama et al. (US PGPub No. 2010/0076426), hereinafter de la Rama. Harlev teaches the catheter of claim 1 as described previously but does not explicitly teach further comprising a shaft electrode mounted to the distal end portion of the shaft. However, in an analogous art, de la Rama teaches an ablation catheter with a shaft electrode mounted to the distal end portion of the shaft (Fig. 2A: shaft electrodes 19 at distal end of shaft 16), which can be used for visualization or mapping purposes (par. 0036: “shaft electrodes 19 are disposed near the distal end of the shaft 16 for visualization and/or mapping purposes”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of Harlev by providing a shaft electrode mounted to the distal end portion of the shaft, as taught by de la Rama. Claims 22 and 78 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Just et al. (US PGPub No. 2019/0239811), hereinafter Just. Harlev teaches the catheter of claim 1 as described previously. Harlev teaches wherein the at least one keyed portion includes a first keyed portion at a proximal end of the respective mesh panel (Figs. 10, 12B: struts 144a; par. 0196) but does not explicitly teach a second keyed portion at a distal end of the mesh electrode panel; the first keyed portion including a first engagement feature configured to interface with a first mating feature of the first coupler at the distal end portion of the shaft and the second keyed portion including a second engagement feature configured to interface with a second mating feature of the second coupler at the distalmost portion of the tip section; wherein the first or second keyed portion comprises one or more projections or recesses, and the mating portion of the first or second coupler comprises one or more complementary recesses or projections; and the first and second keyed portions and the first and second couplers are configured to mechanically couple the mesh electrode panels to the distal end portion of the shaft and to the distalmost portion of the tip section, respectively, and to limit axial or rotational movement of the first or second keyed portion relative to the shaft or the tip section. However, in an analogous art, Just teaches an ablation catheter with expandable elements comprising first and second keyed portions with engagement features each comprising a projection (Figs. 2-3: splines 24 having distal shoulder 36 and proximal shoulder 50) configured to interface with a mating feature of a first and second coupler each comprising a complementary recess (Figs. 2-3: distal first element 30 having plurality of slots 34 and proximal third element 44 having a plurality of channels 48) configured to mechanically couple the elements to the distal end portion of a shaft and the distalmost portion of a tip section, respectively, and to limit axial or rotational movement of the first or second keyed portion relative to the shaft or the tip section, which keeps the expandable elements mechanically coupled to the shaft and distal tip section (par. 0041: “a section configured to restrain the axial slide movement of each of the plurality of splines 24 so as to keep each of the plurality of splines 24 within the first element 30 of the electrode support structure assembly 12. For example and without limitation, the section of the distal end portion 28 can comprise a shoulder 36;” par. 0044: “a section configured to restrain the axial slide movement of each of the plurality of splines 24 so as to keep each of the plurality of splines 24 within the third element 42 of the electrode support structure assembly 12. For example and without limitation, the section of the proximal end portion 26 can comprise a shoulder 50”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of Harlev by providing first and second keyed portions and first and second couplers comprising complementary projections and recesses, as taught by Just, in order to keep the expandable elements (that is, the at least one mesh electrode panel), mechanically coupled to the shaft and the distal tip section, as taught by Just. Claims 76-77 are rejected under 35 U.S.C. 103 as being unpatentable over Harlev in view of Kunis. Regarding claim 76, for the same reasons laid out previously in the rejection of claim 1, Harlev teaches a catheter comprising: a shaft having a proximal end portion and a distal end portion; and a tip section mechanically coupled to the distal end portion of the shaft, wherein the tip section includes a plurality of mesh electrode panels that together define an expandable portion, each mesh electrode panel includes a plurality of struts, and at least one mesh electrode panel defines an electrode to deliver electrical energy to tissue of a patient. Harlev further teaches wherein the expandable portion is moveable between a compressed state and a deployed state, and the expandable portion includes an active body portion configured to deliver electrical energy to tissue of a patient and conform to tissue (par. 0028: “the ablation electrode can include a deformable portion, the deformable portion resiliently flexible from a compressed state to an uncompressed state;” par. 0204: “the deformable portion 142 can deform upon contact with tissue and the deformable portion 142 can engage the tissue through one or more of the cells 147 to resist lateral movement of the deformable portion 142 relative to the tissue. That is, as compared to a closed surface in contact with tissue, the deformable portion 142 will resist unintended movement (e.g., sliding with respect to the tissue) with which it is in contact”), but does not explicitly teach ostial ablation and thus does not explicitly teach that the expandable portion includes a nose portion distal of the active body portion, and while the expandable portion is in the deployed state a distal portion of the active body portion forms a distal surface that is configured to be positioned relatively flat against tissue about an ostium of a pulmonary vein of the patient without contacting tissue inside the pulmonary vein, and the maximum radial dimension of the active body portion is larger than a maximum radial dimension of the ostium such that the active body portion is prevented from entering the pulmonary vein. However, Kunis teaches a cardiac ablation catheter with an expandable potion include an active body portion (Fig. 1: ablation elements 92) and a nose portion distal of the active body portion (Fig. 1: distal tip 94), wherein while the expandable portion is in a deployed state, a distal portion of the active body portion forms a distal surface that is configured to be positioned relatively flat against tissue about an ostium of a pulmonary vein of the patient without contacting tissue inside the pulmonary vein, and the maximum radial dimension of the active body portion is larger than a maximum radial dimension of the ostium such that the active body portion is prevented from entering the pulmonary vein (Figs. 1-2 and 6: maximum radial dimension of active ablation portion 92, 116 larger than maximum radial dimension of ostium and configured to be positioned relatively flat against tissue; par. 0095: “retraction of control shaft 101 causes carrier assembly 105 to transition to a maximum diameter configuration, such as for contacting pulmonary vein ostia”). Kunis teaches that the disclosed ablation catheter configurations provide stabilized contact with pulmonary vein ostial tissue in order to treat atrial fibrillation (par. 0008: “Various ablation techniques have been proposed to treat atrial fibrillation, including […] circumferential ablation of pulmonary vein ostia” and par. 0078: “The ablation elements 92 and other components of carrier assembly 85 are configured to flex to conform to pulmonary vein ostia and other applicable tissues”). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the catheter of Harlev with the shape taught by Kunis, in order to treat atrial fibrillation via stabilized contact with pulmonary vein ostial tissue, as taught by Kunis. Regarding claim 77, the combination teaches the device of claim 77 as described previously. Harlev further teaches the limitations of claim 76 for the same reasons laid out previously in the rejection of claim 1. Response to Arguments Applicant’s arguments, filed 01 May 2026, with respect to the rejection(s) of claim(s) 1 and 22 under 35 U.S.C. 103 have been fully considered and are persuasive. Therefore, in light of the amendments to the claim, the previous rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Harlev (for claim 1), and Harlev and Just (for claim 22). As previously described, Harlev teaches a keyed portion configured to interface with a mating portion of a first coupler at the distal end portion of the shaft, and Just teaches first and second keyed portions and first and second couplers having complementary engagement features and mating features for mechanically coupling expandable elements to the distal end portion of the shaft and to the distalmost portion of the tip section, respectively. Examiner notes that the proposed amendments to claim 1 discussed in the interview on 21 April 2026, which the examiner agreed would overcome the previous rejection of record (that is, the prior art rejection in light of Harlev), recited the limitation of “a recessed portion” in the first or second coupler, while the actual amendments to claim 1 recite the limitation of “a mating portion” in the first or second coupler. The limitation “a mating portion” is broader in scope than “a recessed portion,” as it does not recite a particular connection structure in the first or second coupler, and therefore does not distinguish over the Harlev reference. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DAVINA E LEE whose telephone number is (571)272-5765. The examiner can normally be reached Monday through Friday between 8:00 AM and 5:30 PM (ET). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JOANNE M RODDEN can be reached at (303) 297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /D.E.L./Examiner, Art Unit 3794 /JOANNE M RODDEN/Supervisory Patent Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Show 5 earlier events
Oct 20, 2025
Final Rejection mailed — §103
Jan 14, 2026
Response after Non-Final Action
Feb 04, 2026
Non-Final Rejection mailed — §103
Apr 10, 2026
Interview Requested
Apr 21, 2026
Applicant Interview (Telephonic)
Apr 21, 2026
Examiner Interview Summary
May 01, 2026
Response Filed
Sep 01, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773148
Implantable Nerve Transducer with Solid-State Battery
5y 8m to grant Granted Oct 27, 2026
Patent 12773255
IMPEDANCE CONTROLLED RF TRANSSEPTAL PERFORATION
5y 5m to grant Granted Oct 27, 2026
Patent 12765943
Multi-lumen thrombectomy devices
5y 3m to grant Granted Oct 20, 2026
Patent 12758225
SURGICAL DEVICE FOR PERFORMING COLPOTOMY ON PATIENT
3y 7m to grant Granted Oct 13, 2026
Patent 12672892
PROBE
5y 7m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
39%
Grant Probability
57%
With Interview (+17.6%)
High
PTA Risk
Based on 59 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month